Biotron Limited
BITRF
$0.01
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -2.75% | -- | |||
| Total Revenue | -2.75% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -2.75% | -- | |||
| SG&A Expenses | -2.74% | 19.61% | |||
| Depreciation & Amortization | -4.00% | -59.68% | |||
| Other Operating Expenses | -2.80% | -19.55% | |||
| Total Operating Expenses | -2.75% | -46.76% | |||
| Operating Income | -2.74% | 133.21% | |||
| Income Before Tax | -2.74% | 133.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.74% | 133.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.74% | 133.53% | |||
| EBIT | -2.74% | 133.21% | |||
| EBITDA | -2.75% | 133.58% | |||
| EPS Basic | 0.00% | 137.50% | |||
| Normalized Basic EPS | 0.00% | 140.00% | |||
| EPS Diluted | 0.00% | 125.00% | |||
| Normalized Diluted EPS | 0.00% | 120.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 9.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||